CD19/CD22 dual‐targeting chimeric antigen receptor T‐cell therapy bridging to allogeneic haematopoietic stem cell transplantation for B‐cell acute lymphoblastic leukaemia delays platelet recovery and increases risks of cytomegalovirus and Epstein–Barr virus viremia after transplantation

Detalles Bibliográficos
Autores principales: Li, Shijia, Ge, Jianrong, Zhou, Shiyuan, Zhu, Wenjuan, Han, Yue, Chen, Suning, Xue, Shengli, Wang, Ying, Qiu, Huiying, Wu, Xiaojin, Wu, Depei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Letter to the Journal
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600828/
https://www.ncbi.nlm.nih.gov/pubmed/37882317
http://dx.doi.org/10.1002/ctm2.1459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600828/
https://www.ncbi.nlm.nih.gov/pubmed/37882317
http://dx.doi.org/10.1002/ctm2.1459

Ejemplares similares